ELEVEN BIOTHERAPEUTICS INC's ticker is EBIO and the CUSIP is 286221106. A total of 26 filers reported holding ELEVEN BIOTHERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,000 | – | 600 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 600 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 600 | +20.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | -50.0% | 500 | -16.7% | 0.00% | – |
| Q3 2016 | $2,000 | +100.0% | 600 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | – | 600 | -7.8% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 651 | +8.5% | 0.00% | – |
| Q4 2015 | $2,000 | +100.0% | 600 | 0.0% | 0.00% | – |
| Q3 2015 | $1,000 | -50.0% | 600 | 0.0% | 0.00% | – |
| Q2 2015 | $2,000 | -50.0% | 600 | +57.1% | 0.00% | – |
| Q1 2015 | $4,000 | -81.8% | 382 | -79.7% | 0.00% | – |
| Q4 2014 | $22,000 | +57.1% | 1,886 | +50.2% | 0.00% | – |
| Q3 2014 | $14,000 | +600.0% | 1,256 | +705.1% | 0.00% | – |
| Q2 2014 | $2,000 | -66.7% | 156 | -49.8% | 0.00% | – |
| Q1 2014 | $6,000 | – | 311 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|